Skip to main content

Table 1 The demographic features of the study patients

From: Evaluation of the prevalence of coronary artery disease in patients with valvular heart disease

  MS (MVR) (n = 72) MR (MVR) (n = 93) AS (AVR) (n = 40) AR (AVR) (n = 36) P value
Age 52.23 ± 10.05 56.62 ± 12.07 63.52 ± 13.36 55.19 ± 14.21 0.000
HT (%) 5 (15.6) 15 (46.9) 7 (21.9) 5 (15.6) 0.008
DM (%) 20 (18.7) 47 (43.9) 22 (20.6) 18 (16.8) 0.284
History of Smoking (%) 22 (27.5) 28 (35) 15 (18.8) 15 (18.8) 0.547
TG (mg/dL) 116.18 ± 65.85 147.84 ± 95.40 143.32 ± 95.17 147.38 ± 75.42 0.087
LDL (mg/dL) 114.25 ± 32.06 112.37 ± 37.05 122.87 ± 39.35 114.88 ± 31.36 0.468
  1. HT, hypertension; DM, diabetes mellitus; TG, triglyceride; LDL, low-density lipoproteins; MS, mitral stenosis; MR, mitral regurgitation; MVR, mitral valve replacement; AS, aortic stenosis; AR, aortic regurgitation; AVR, aortic valve replacement.